Skip to search formSkip to main contentSkip to account menu

The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and…

TLDR
The DISC-2 is a reliable and economical tool for assessing child psychopathology and the 2.3 version of the instrument provides a significant improvement over earlier versions.
View on PubMed (opens in a new tab)

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

TLDR
These secondary analyses confirm the primary findings and clarify clinical decisions about the choice between multimodal and unimodal treatment with medication.
View on PubMed (opens in a new tab)

Coming to terms with the terms of risk.

TLDR
This work defines risk and a risk factor (protective factor) and their potency, set out the conceptual basis of the methods by which risk factors are identified and potency demonstrated, and proposes criteria for establishing the status of a risk factors as a fixed or variable marker or a causal risk factor.
View on PubMed (opens in a new tab)

The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.

TLDR
Type or intensity of 14 months of treatment for ADHD in childhood does not predict functioning 6 to 8 years later, and early ADHD symptom trajectory regardless of treatment type is prognostic, implying that children with behavioral and sociodemographic advantage, with the best response to any treatment, will have the best long-term prognosis.
View on PubMed (opens in a new tab)

DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents.

TLDR
The results support the decision to subdivide the heterogeneous category of DSM-III-R attention deficit hyperactivity disorder into three subtypes and the resulting DSM-IV definition appears to be somewhat less biased toward the symptom pattern typical of elementary school boys.
View on PubMed (opens in a new tab)

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups.

TLDR
Three clinical profiles are indicated, ADHD co-occurring with internalizing disorders (principally parent-reported anxiety disorders) absent any concurrent disruptive disorder (ADHD + ANX), ADHD Co-occurred with ODD/CD but no anxiety (AD HD + ODD /CD), and ADHD with both anxiety and O DD/CD may be sufficiently distinct to warrant classification as ADHD subtypes different from "pure" ADHD with neither comorbidity.
View on PubMed (opens in a new tab)

Criterion validity of the NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3).

TLDR
Examination of the criterion validity of the NIMH Diagnostic Interview Schedule for Children showed moderate to good validity across a number of diagnoses, and suggested some specific diagnostic areas in which further revision of the DISC is warranted.
View on PubMed (opens in a new tab)

Parent and child contributions to diagnosis of mental disorder: are both informants always necessary?

TLDR
Overall findings suggest that most "discrepant" diagnoses reflect meaningful clinical conditions, but in some instances, however, diagnoses reported by one but not the other informant should be treated with caution.
View on PubMed (opens in a new tab)

National trends in the use of psychotropic medications by children.

TLDR
There was a marked expansion in use of psychotropic medications by children, especially stimulants and antidepressants, between 1987 and 1996, especially antidepressants and stimulants.
View on PubMed (opens in a new tab)

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and Applications for Primary Care Providers

TLDR
Primary analyses revealed that Comb had a significant incremental effect over MedMgt (with a small effect size for this comparison) when categorical indicators of excellent response and when composite outcome measures were used.
View on Wolters Kluwer (opens in a new tab)
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)